FDA is facilitating access to COVID-19 convalescent plasma

The Food and Drug Administration (FDA) says they are committed to doing everything we can to provide timely response efforts to this pandemic and facilitate access to investigational drugs for use in patients with serious or immediately life-threatening COVID-19 infections. One investigational treatment being explored for COVID-19 involves the use of convalescent plasma collected from recovered ["]

The post FDA is facilitating access to COVID-19 convalescent plasma appeared first on Outbreak News Today.